ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,061.44
-1.07%
US Tech 100
17,092.00
-1.26%
다우존스 지수
37,933.27
-1.18%
Bitcoin
60,143.64
-5.79%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. Nevro Corp (NVRO)

  7. Nevro Corp (NVRO) 뉴스

NVRO Nevro Corp

10.655
-0.765 (-6.70%)
최종 업데이트: 04:25:55
15분 지연
기업명 주식 심볼 시장 주식 타입
Nevro Corp NVRO NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-0.765 -6.70% 10.655 04:25:55
개장가 저가 고가 종가 전일 종가
11.25 10.60 11.348 11.42
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/04/202421:30PRNUSNevro to Report First-Quarter 2024 Financial Results and..
12/03/202405:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202405:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202405:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202405:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202405:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202406:10PRNUSNevro Receives FDA 510(k) Clearance to Use SI Fixation..
24/02/202407:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/02/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202406:16EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/02/202406:11EDGAR2Form 8-K - Current report
22/02/202406:09EDGAR2Form 8-K - Current report
22/02/202406:06PRNUSNevro Enters Into Cooperation Agreement With Engaged Capital
22/02/202406:05PRNUSNevro Reports Fourth-Quarter and Full-Year 2023 Financial..
15/02/202405:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202405:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/02/202406:30PRNUSNevro Announces Consensus Statement Supporting..
30/01/202406:30PRNUSNevro to Report Fourth-Quarter and Full-Year 2023 Financial..
19/01/202406:15PRNUSNevro Announces Positive Coverage Update from Carelon..
18/01/202406:15PRNUSNevro to Highlight 25 Scientific Abstracts at 2024 North..
11/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
11/01/202407:26EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/01/202422:41EDGAR2Form 8-K - Current report
09/01/202422:30PRNUSNevro Announces Preliminary Fourth-Quarter and Full-Year..
09/01/202407:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:15PRNUSNevro to Present at 42nd Annual J.P. Morgan Healthcare..
04/01/202406:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
06/12/202307:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202320:07EDGAR2Form 8-K - Current report
01/12/202307:19PRNUSNevro Announces Acquisition of Vyrsa™ Technologies
01/12/202306:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202306:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202321:00PRNUSNevro Delivers Long-Term Relief with High-Frequency Spinal..
15/11/202308:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202305:07EDGAR2Form 8-K - Current report
02/11/202305:01PRNUSNevro Reports Third Quarter 2023 Financial Results, Provides..
07/10/202306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202320:00PRNUSNevro to Report Third Quarter 2023 Financial Results
04/10/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/09/202320:00PRNUSNew Data Demonstrate the Health Economic Benefits of Nevro's..
07/09/202306:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202305:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NYSE
NVRO
Nevro
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유